Pharmacokinetics of 250 μg anti-D IgG in the third trimester of pregnancy: An observational study

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 5, 2012, Pages 587-592

  Tiblad, Eleonor ^a   Wikman, Agneta ^a   Rane, Anders ^a   Jansson, Yvonne ^a   Westgren, Magnus ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antenatal anti D prophylaxis; antenatal Rh prophylaxis; anti D immunoglobulin; pharmacokinetics; plasma concentration

Indexed keywords

RHESONATIV; RHESUS D ANTIBODY; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BIRTH; BLOOD SAMPLING; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; FETUS; FLOW CYTOMETRY; GESTATIONAL AGE; HUMAN; MOTHER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; PUERPERIUM; RHESUS INCOMPATIBILITY; THIRD TRIMESTER PREGNANCY;

ADULT; FEMALE; HALF-LIFE; HUMANS; INJECTIONS, INTRAMUSCULAR; ISOANTIBODIES; PHARMACOKINETICS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN; YOUNG ADULT;

EID: 84860249955     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2012.01377.x     Document Type: Article

References (17)

1. Bowman JM, Pollock JM, Penston LE,. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang. 1986; 51: 117-21.
2. Bowman J., Rh-immunoglobulin: Rh prophylaxis. Best Pract Res Clin Haematol. 2006; 19: 27-34.
3. Crowther CA, Keirse MJ,. Anti-D administration in pregnancy for preventing rhesus alloimmunisation. Cochrane Database Syst Rev. 2000: CD000020.
4. Koelewijn JM, de Haas M, Vrijkotte TG, Bonsel GJ, van der Schoot CE,. One single dose of 200 μg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy. Transfusion. 2008; 48: 1721-9.
5. Hogstedt S, Lindberg B, Peng DR, Regardh CG, Rane A., Pregnancy-induced increase in metoprolol metabolism. Clin Pharmacol Ther. 1985; 37: 688-92.
6. Hogstedt S, Lindberg B, Rane A., Increased oral clearance of metoprolol in pregnancy. Eur J Clin Pharmacol. 1983; 24: 217-20.
7. Wadelius M, Darj E, Frenne G, Rane A., Induction of CYP2D6 in pregnancy. Clin Pharmacol Ther. 1997; 62: 400-7.
8. Bichler J, Schondorfer G, Pabst G, Andresen I., Pharmacokinetics of anti-D IgG in pregnant RhD-negative women. BJOG. 2003; 110: 39-45.
9. MacKenzie IZ, Roseman F, Findlay J, Thompson K, Jackson E, Scott J, et al,. The kinetics of routine antenatal prophylactic intramuscular injections of polyclonal anti-D immunoglobulin. BJOG. 2006; 113: 97-101.
10. Trolle B., Prenatal Rh-immune prophylaxis with 300 micrograms immune globulin anti-D in the 28th week of pregnancy. Acta Obstet Gynecol Scand. 1989; 68: 45-7.
11. Eklund J, Hermann M, Kjellman H, Pohja P., Turnover rate of anti-D IgG injected during pregnancy. Br Med J (Clin Res Ed). 1982; 284: 854-5.
12. Bowman JM, Pollock JM,. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures. Transfus Med Rev. 1987; 1: 101-12.
13. Choavaratana R, Uer-Areewong S, Makanantakosol S., Feto-maternal transfusion in normal pregnancy and during delivery. J Med Assoc Thai. 1997; 80: 96-100.
14. Zipursky A, Pollock J, Neelands P, Chown B, Israels LG,. The transplacental passage of foetal red blood-cells and the pathogenesis of Rh immunisation during pregnancy. Lancet. 1963; 2: 489-93.
15. Anonymous. World Health Organisation. Prevention of Rh sensitisation. Geneva 1971: 29 Contract No.: WHO Technical Report Series 468.
16. Seavey MM, Mosmann TR,. Immunoregulation of fetal and anti-paternal immune responses. Immunol Res. 2008; 40: 97-113.
17. Kumpel BM,. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis. Transfusion. 2006; 46: 1652-6.